Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Reliable Information for the Skeptical Family Doctor


Published on

A presentation given by Dr. Janice Mann at the 40th Annual Dalhousie February Refresher on Therapeutics, February 20, 2014.

  • Be the first to comment

  • Be the first to like this

Reliable Information for the Skeptical Family Doctor

  1. 1. Reliable Information for the Skeptical Family Doctor Presentation by Dr. Janice Mann February 20th 2014 Dal Refresher
  2. 2. Disclosure: • I am an employee of CADTH • I am a physician, not currently practicing • I HTA
  3. 3. How Did We Get Here? At FMF 2012: • Dr. Mike Allan (AB) at his plenary address urged family doctors to be skeptical of their sources of information • He pointed to CADTH as one reliable source of independent, balanced evidence and encouraged attendees to seek out this kind of information But: • Most family physicians are not familiar with CADTH or our work in HTA How I got here is another story…
  4. 4. What is HTA?
  5. 5. What is a health technology? • Pharmaceuticals (drugs, blood products, vaccines) • Diagnostics • Medical, dental, surgical devices and procedures
  6. 6. Health Technology Assessment • Systematic evaluation of the evidence on the properties, effects, and/or impacts of health care technology
  7. 7. CADTH • An independent, not-for-profit producer and broker of health technology assessments. • Health care decision-makers rely on our work to make evidence-informed policy and practice decisions about drugs and other health technologies.
  8. 8. Other HTA Producers in Canada INESSS (formerly AETMIS) Quebec Health Technology Assessment & Innovation (HTAI) – Alberta Health Alberta www.albertahealthservi Centre for Evaluation of Medicines Ontario Centre for Health Economics and Policy Analysis (CHEPA) Ontario Centre for Health Services and Policy Research British Columbia Institute for Health Economics (IHE) Alberta Institute for Clinical Evaluative Sciences (ICES) Ontario
  9. 9. Other HTA Producers in Canada (con’t) Ontario Health Technology Advisory Committee Ontario nce/publications-and- ohtac-recommendations The Technology Assessment Unit of the McGill University Health Centre Quebec The Therapeutics Initiative. Evidence Based Drug Therapy Ontario Toronto Health Economics and Technology Assessment (THETA) Ontario home Programs for Assessment of Technology in Health (PATH) Ontario www.path-
  10. 10. Why use HTA Evidence in Clinical Practice? • Rigorous • Balanced • Relevant • Synthesis of large volume of research • Freely available • Positive experience of family physicians and primary care clinicians who have used HTA in practice “You changed my practice”
  11. 11. How to use HTA Evidence in Practice • HTA provides the EVIDENCE piece to the decision- making puzzle. • Only you can make the best decision for your patient based on the evidence as well as your clinical experience, clinical judgment, and knowledge of your patient.
  12. 12. How can I find HTA evidence to use in my practice?
  13. 13. On the Web • or • For Clot and Stroke Prevention: • For Evidence on Lab Tests: • For rapid evidence reviews on clinical health technology questions: • – True or False Quizzes • Sign up for the CADTH E-alert:
  14. 14. True or False Statements based on HTA evidence from CADTH (bottom right corner of CMAJ homepage) True and False Archives: archives.xhtml
  15. 15. Via Social Media @CADTH_ACMTS ian-agency-for-drugs-and-technologies- in-health
  16. 16. Get to Know Us • Lisa Farrell – Nova Scotia • Stephanie Smith – New Brunswick • Joyce Thompson – Prince Edward Island • Sheila Tucker – Newfoundland and Labrador • Janice Mann – Knowledge Mobilization
  17. 17. Attend our Symposium
  18. 18. Using HTA evidence in your practice
  19. 19. This tool helps to inform prescribing decisions when the decision to start anticoagulation has been made. It includes key research findings, information about warfarin and the new oral anticoagulants (NOACs), and a warfarin/NOAC comparison chart. http://clots.cadth.c a/en/tools-and- resources/publicati on/6
  20. 20. Rapid Response Reports Example: Fluconazole Administration for the Treatment of Ductal Yeast Infections: Clinical Effectiveness and Safety Research Questions: 1. What is the clinical evidence for the effectiveness of six-week fluconazole administration for the treatment of ductal yeast infections in breastfeeding mothers? 2. What is the short- and long-term safety of six-week fluconazole administration for the treatment of ductal yeast infections in breastfeeding mothers?
  21. 21. Using Evidence from Rapid Response in Practice Results: No evidence found Putting the results into clinical practice: “Dear Patient” Letter Next steps: Patient and provider info pamphlet
  22. 22. How can I get involved with HTA? • Provide feedback on CADTH research and products. • Provide informal input as we develop new projects. • Become a member of a CADTH committee. • Connect with HTA producers or users in your area. • Submit a request for a Rapid Response report*
  23. 23. @JustSayIt_MD @CADTH_ACMTS